Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
1.35M
-
Shares change
-
+108K
-
Total reported value, excl. options
-
$8.51M
-
Value change
-
+$664K
-
Put/Call ratio
-
0.25
-
Number of buys
-
11
-
Number of sells
-
-12
-
Price
-
$6.30
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q3 2015
39 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q3 2015.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.35M shares
of 65.9M outstanding shares and own 2.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (492K shares), AMERICAN INTERNATIONAL GROUP INC (227K shares), RAYMOND JAMES & ASSOCIATES (128K shares), GEODE CAPITAL MANAGEMENT, LLC (128K shares), Skylands Capital, LLC (52.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (46.5K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (46.1K shares), BlackRock Fund Advisors (39.8K shares), GLENMEDE TRUST CO NA (27.6K shares), and NORTHERN TRUST CORP (23.7K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.